Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan-Yu Chen

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Huan Jing Ke Xue= Huanjing Kexue|February 20, 2015
[Pollution characteristics and ecological risk of polybrominated diphenyl ethers (PBDEs) in river sediments from an electrical equipment dismantling area]Xuan-Yu Chen, Nan-Dong Xue, Shi-Lei Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Nivolumab and relatlimab for the treatment of melanomaXuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|December 11, 2023
Fundus Tessellated Density of Pathologic MyopiaHai-Long He, Yi-Xin Liu, Xuan-Yu Chen, et al.
Mathematical Biosciences and Engineering : MBE|November 17, 2019
Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancerGuo Bing Lin, Cun Ming Zhang, Xuan Yu Chen, et al.
Frontiers in Oncology|June 5, 2026
miR-17: from developmental regulatory hub to molecular engine driving tumourigenesisMin Zhang, Yu Rong Ma, Xuan Yu Chen, et al.
Journal of Affective Disorders|May 13, 2022
Objectification and ambiguity of body image in women with Polycystic Ovary Syndrome: A mixed-method studyMargaret X C Yin, Ling-Li Leng, Zurong Liang, et al.
Molecular Cancer|February 1, 2023
CAR T cells: engineered immune cells to treat brain cancers and beyondZoufang Huang, Saikat Dewanjee, Pratik Chakraborty, et al.
Ophthalmology and Therapy|March 5, 2024
A Novel Grading System for Diffuse Chorioretinal Atrophy in Pathologic MyopiaYu-Ning Niu, Hai-Long He, Xuan-Yu Chen, et al.
Frontiers in Pharmacology|May 17, 2024
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cellsXuan-Yu Chen, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Huan Jing Ke Xue= Huanjing Kexue|February 20, 2015
[Pollution characteristics and ecological risk of polybrominated diphenyl ethers (PBDEs) in river sediments from an electrical equipment dismantling area]Xuan-Yu Chen, Nan-Dong Xue, Shi-Lei Zhang, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 22, 2023
Nivolumab and relatlimab for the treatment of melanomaXuan-Yu Chen, Yi-Dong Li, Yuhao Xie, et al.
Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.)|December 11, 2023
Fundus Tessellated Density of Pathologic MyopiaHai-Long He, Yi-Xin Liu, Xuan-Yu Chen, et al.
Mathematical Biosciences and Engineering : MBE|November 17, 2019
Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancerGuo Bing Lin, Cun Ming Zhang, Xuan Yu Chen, et al.
Frontiers in Oncology|June 5, 2026
miR-17: from developmental regulatory hub to molecular engine driving tumourigenesisMin Zhang, Yu Rong Ma, Xuan Yu Chen, et al.
Journal of Affective Disorders|May 13, 2022
Objectification and ambiguity of body image in women with Polycystic Ovary Syndrome: A mixed-method studyMargaret X C Yin, Ling-Li Leng, Zurong Liang, et al.
Molecular Cancer|February 1, 2023
CAR T cells: engineered immune cells to treat brain cancers and beyondZoufang Huang, Saikat Dewanjee, Pratik Chakraborty, et al.
Ophthalmology and Therapy|March 5, 2024
A Novel Grading System for Diffuse Chorioretinal Atrophy in Pathologic MyopiaYu-Ning Niu, Hai-Long He, Xuan-Yu Chen, et al.
Frontiers in Pharmacology|May 17, 2024
Multidrug resistance transporters P-gp and BCRP limit the efficacy of ATR inhibitor ceralasertib in cancer cellsXuan-Yu Chen, Zhuo-Xun Wu, Jing-Quan Wang, et al.
Nature Reviews. Clinical Oncology|July 30, 2025
Understanding and overcoming multidrug resistance in cancerMinghua Ge, Xuan-Yu Chen, Ping Huang, et al.
Pageof 5